EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS133-23516 
Organism
Homo sapiens 
Tissue/cell
melanoma 
Coordinate
chr3:194246700-194249340 
Target genes
Number: 6             
NameEnsembl ID
TF binding sites/motifs
Number: 51             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr3:194247698-194247716GGAAGGAAGGAAGGAAGA+10.05
EWSR1-FLI1MA0149.1chr3:194247694-194247712GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr3:194248749-194248767CCCGCCTTCCTTCCCTCT-6.03
EWSR1-FLI1MA0149.1chr3:194248620-194248638TCTTCCTTCTTTCTTTTC-6.05
EWSR1-FLI1MA0149.1chr3:194248608-194248626CTTCTCTTCCTTTCTTCC-6.09
EWSR1-FLI1MA0149.1chr3:194248723-194248741CCTTGCTTCCATTCTTTC-6.09
EWSR1-FLI1MA0149.1chr3:194248553-194248571ATGCCCTTCCTTCCTTCC-6.14
EWSR1-FLI1MA0149.1chr3:194247674-194247692GAAAGAAAGGAAAGAAAG+6.33
EWSR1-FLI1MA0149.1chr3:194247670-194247688GAAAGAAAGAAAGGAAAG+6.34
EWSR1-FLI1MA0149.1chr3:194248616-194248634CCTTTCTTCCTTCTTTCT-6.56
EWSR1-FLI1MA0149.1chr3:194247678-194247696GAAAGGAAAGAAAGAAGG+6.62
EWSR1-FLI1MA0149.1chr3:194248612-194248630TCTTCCTTTCTTCCTTCT-6.79
EWSR1-FLI1MA0149.1chr3:194247706-194247724GGAAGGAAGAAAGAAAGA+6.81
EWSR1-FLI1MA0149.1chr3:194248699-194248717CTTTTCTTCCTTCCTTCT-6.95
EWSR1-FLI1MA0149.1chr3:194248719-194248737CCTTCCTTGCTTCCATTC-6.98
EWSR1-FLI1MA0149.1chr3:194248565-194248583CCTTCCTCCTTCCCTTCC-7.05
EWSR1-FLI1MA0149.1chr3:194248561-194248579CCTTCCTTCCTCCTTCCC-7.08
EWSR1-FLI1MA0149.1chr3:194248711-194248729CCTTCTTTCCTTCCTTGC-7.71
EWSR1-FLI1MA0149.1chr3:194247686-194247704AGAAAGAAGGAAGGAAGG+7.85
EWSR1-FLI1MA0149.1chr3:194248557-194248575CCTTCCTTCCTTCCTCCT-7.85
EWSR1-FLI1MA0149.1chr3:194247682-194247700GGAAAGAAAGAAGGAAGG+7.87
EWSR1-FLI1MA0149.1chr3:194247702-194247720GGAAGGAAGGAAGAAAGA+8.26
EWSR1-FLI1MA0149.1chr3:194248703-194248721TCTTCCTTCCTTCTTTCC-8.52
EWSR1-FLI1MA0149.1chr3:194248715-194248733CTTTCCTTCCTTGCTTCC-8.52
EWSR1-FLI1MA0149.1chr3:194247690-194247708AGAAGGAAGGAAGGAAGG+9.09
EWSR1-FLI1MA0149.1chr3:194248707-194248725CCTTCCTTCTTTCCTTCC-9.17
Foxd3MA0041.1chr3:194249166-194249178GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr3:194249170-194249182GTTTGTTTGTTT+6.32
IRF1MA0050.2chr3:194248652-194248673TCTTTCTTTCTTTTTCTTTCT+6.14
IRF1MA0050.2chr3:194247659-194247680AAAAAAAAAAAGAAAGAAAGA-6.25
IRF1MA0050.2chr3:194247719-194247740AAAGAAAAAAAGAAAGAAAGA-6.34
IRF1MA0050.2chr3:194248638-194248659TCTTTCTTTCTCTTTCTTTCT+6.76
IRF1MA0050.2chr3:194247729-194247750AGAAAGAAAGAGAAAGAAAGA-6.76
IRF1MA0050.2chr3:194247743-194247764AGAAAGAAAGAGAAAGAAAGA-6.76
ZNF263MA0528.1chr3:194248703-194248724TCTTCCTTCCTTCTTTCCTTC-6.02
ZNF263MA0528.1chr3:194248597-194248618CCTCCCCTCCCCTTCTCTTCC-6.13
ZNF263MA0528.1chr3:194248600-194248621CCCCTCCCCTTCTCTTCCTTT-6.1
ZNF263MA0528.1chr3:194248569-194248590CCTCCTTCCCTTCCCTCCCTT-6.21
ZNF263MA0528.1chr3:194248741-194248762CCTCTCCCCCCGCCTTCCTTC-6.21
ZNF263MA0528.1chr3:194248584-194248605TCCCTTCCCCTCCCCTCCCCT-6.25
ZNF263MA0528.1chr3:194248594-194248615TCCCCTCCCCTCCCCTTCTCT-6.33
ZNF263MA0528.1chr3:194248573-194248594CTTCCCTTCCCTCCCTTCCCC-6.34
ZNF263MA0528.1chr3:194247699-194247720GAAGGAAGGAAGGAAGAAAGA+6.36
ZNF263MA0528.1chr3:194248579-194248600TTCCCTCCCTTCCCCTCCCCT-6.44
ZNF263MA0528.1chr3:194248737-194248758TTTCCCTCTCCCCCCGCCTTC-6.51
ZNF263MA0528.1chr3:194248565-194248586CCTTCCTCCTTCCCTTCCCTC-6.79
ZNF263MA0528.1chr3:194248589-194248610TCCCCTCCCCTCCCCTCCCCT-6.91
ZNF263MA0528.1chr3:194247691-194247712GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr3:194247703-194247724GAAGGAAGGAAGAAAGAAAGA+6
ZNF263MA0528.1chr3:194247695-194247716GAAGGAAGGAAGGAAGGAAGA+7.03
ZNF263MA0528.1chr3:194248556-194248577CCCTTCCTTCCTTCCTCCTTC-7.79
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_45578chr3:194246668-194248716Osteoblasts
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr3194247870194248550
Number: 1             
IDChromosomeStartEnd
GH03I194526chr3194246819194249105
Enhancer Sequence
TTGTTTTTTT AGTAGAGATG GAGTTTCTCC ATGTTGGTCA GGCCAGTCTG AAACTCCTGA 60
CCTCAGGTGA TCCACCTGCC TCGGCCTCCC AAAGTGCTGG GATTATAGGC GTGAACCACT 120
GTGCCTGGCC TAGTGTACCC ATTCTTTAAG GCCCCACTCC TGTCCCTTCT CCCTACCACT 180
GTCCCTGCCT CTTACCCAAC CAGTTGTCTT TCTCTCTTGT AAACTCCAAC ATTTCACATT 240
TATCTCTTGT TATATGTGGC TAGTAACCAT TGATCACCTT CCTTATGTTT GCTCATGTTT 300
TACCTTCCCA GCTAGTCTGT ATGCTTCTCG AAGGCTAGGC TCATATTGCA CATCATTGTA 360
TCTTCTTTGC CCTCTGGAAG GCTAGGATCA TATTGCGCAT CATTGTATCT TCTTTGCCCT 420
CTGGAAGGCT AGGATCATAT TGCGCATCAT TGTATCTTCT TTGCCCCCGG AGCATGGCCT 480
GCCTAGAGGG GATATTTGGT CATTTCTTTT TCATTGATTG GTTTTATAAC CACCATAATG 540
TTTGAACTCC TTAATGTGGC CTACATGGAT TGGTCTTTGC CACCCTATTT GGCCTCATTT 600
GTGTCTCCTC CCCCTTTACA TTTTATACCT AGCCATCCTC AATACCAGCC AGTTCCTTAG 660
AAATTCCATG GGCCAAGCAC AGTGGCTCAT CACACCTGTA ATCCCAGCAC TTTGGGAGGC 720
CGAAGCGGGC GGATCACCTG AGGTCAGTAG TTCCAGACCA GCCTGACCAA CACGGTGAAA 780
CCCCATCTCT ACTAAAATAC AAAAATTAGC CAGTTGTGGT GGTGCACGCC TGTAATCCCA 840
GCTTCTCGGG AGGCTGAGGC AGGAGAATCG CTTGAACCCA GGAGGTGGGG GTTGCAGTGA 900
GCCCAGATCG CCCTACTGCA CTCTAGCTTG GGTGACAGGG CAGTGACCCT GTCTCAAAAA 960
AAAAAAAAAA GAAAGAAAGA AAGGAAAGAA AGAAGGAAGG AAGGAAGGAA GGAAGAAAGA 1020
AAGAAAAAAA GAAAGAAAGA GAAAGAAAGA AAGAGAAAGA AAGAAAAGAA GAAAGAAAGA 1080
AAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA 1140
AAAATTGCAG CCATGACACC TCACACAGCT TCCTCTGCCG GAACACTCAT CTCCTCTTCT 1200
GTCTGGTTGA CTCTTCTCAA CATTTGCATC TCAATCTGGG AATTACTTCC TAACGAGAAG 1260
TCTTCCCCTG GACTTCATCA GAAAGTACAA ATTAGTAAGA TTGCGCCAGC AAAATGCGTA 1320
GTGTGTGAGA AAGCACTTAG CAAGAGGAAA TGAGAAACAT TCACGTCCAC TTACTCATGA 1380
GCTTGCTCCA GCTTCTTCTT CTCCTGTCCC CTAGTTCCCT CTGGATGTCA GCCATCTGAA 1440
ATTACTCACA GGACATCTGA ATGCACTTTG TTTTATCATA CAAAGTGTGC CTTTGTACAC 1500
ACTTTTCTTC CGTTTTTTTT CTTCCTTTTT TTTTTTTTTT TGGAGGCCAA GTGCACTGAC 1560
GCCATTTCGG CTCATTGCAA CCCCTGCCTC CTGGGTTCAA GCTATTCTCC TGCCTCAGCC 1620
TCCCAAGTAG CTGGGACTAC AGGTGTGTAC CACCATGCCT GACTAATTTT TGTATTTTTA 1680
GTAGAGATGG GGTTTCACCA TGTTGGCCAG GCTGGTCTCG AACCCTGACC TCAAGTGATC 1740
CACCCACCTC GGCCTCTCAA AGTTCTGGGA TTACAGGTGT GAGCCATTAT GCCCAGCCTG 1800
TACACACTAA ACATTTTTCA TTTTTTCATT CTTCCTAGGA TTCCATTTAA TCCATGCCCT 1860
TCCTTCCTTC CTCCTTCCCT TCCCTCCCTT CCCCTCCCCT CCCCTCCCCT TCTCTTCCTT 1920
TCTTCCTTCT TTCTTTTCTC TTTCTTTCTC TTTCTTTCTT TCTTTTTCTT TCTTTCTTCT 1980
GTTCTTTCCT TCTTTTGTTC TTTTCTTCCT TCCTTCTTTC CTTCCTTGCT TCCATTCTTT 2040
CCCTCTCCCC CCGCCTTCCT TCCCTCTCTC TCCACACCCC TACCCCCGCC CTTCTCTTTC 2100
TTTTGAGAGT CTTACTCTAT TGCCCAGGAT GGAGTGCAAT GGTGCCATCA CAGCTCACTG 2160
CAACCTCTGC CTCCCGGGTT CAAGTGATCT TCGTGCCTCA GCCACCTGAG TAGCTGTGGG 2220
ATTACAAGTA TCTGCAATCA GGTCTGGCTA ATTTTTGTAT TTTTAGTAGA TATGGGGTTT 2280
CACCGTGTTG GCCAGGCTGG TCTTCAACTC CTGGCCTCAA GTGATCCACC CACCTCGGTC 2340
TCCCAAAGTG CTGGGATTAA AGGCATGAGC CACCGCGTGG CCTAATCCAT GCCCTTTCTT 2400
CACCTAATTA ACTCCTACTC ATTTTTCAAT GCCCAGCCAA GGGGTTTGTA TAATGGTGCA 2460
ATTTTTGTTT GTTTGTTTGT TTTATGAGAC GGTCTTGCTC TGTCACCCAG GCTGGAGTGC 2520
AGTGGTACGA TTTTGGCTCA CTGCAACCTC TGCCTCCCCG GGCTCAAGCA ATTCTCCTGC 2580
CTCCCTCCCG AGCAGCTGGA ATTACAAGTG CACACCACCA CACGCTGCTA ATTTTTTTGT 2640